Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1998
05/19/1998US5753648 Tricyclic benzazepine vasopressin antagonists
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753646 Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
05/19/1998US5753643 Heterocyclic compounds
05/19/1998US5753641 Method of treatment for benign prostatic hyperplasia
05/19/1998US5753640 Administering dehydroepiandrosterone or derivatives
05/19/1998US5753639 Low dose androgenic compounds for prevention and treatment of endometriosis
05/19/1998US5753637 Method of treating acne conditions
05/19/1998US5753636 Containing oxytetracycline complexed with magnesium, polyvinylpyrrolidone, a basic amino acid, and an additive in a solvent; free of chloride ions; solubility, stability
05/19/1998US5753635 Purine derivatives and their use as anti-coagulants
05/19/1998US5753633 Method of inhibiting bone resorption
05/19/1998US5753631 Intercellular adhesion mediators
05/19/1998US5753630 Method for treating and inhibiting gastric and duodenal ulcers
05/19/1998US5753629 Amino acid derivative antibiotics; viricides
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753622 Use of epidermal growth factor as a gastrointestinal therapeutic agent
05/19/1998US5753611 Pharmaceutical composition having site-specific delivery
05/19/1998US5753491 Use of neuro-derived fetal cell lines for transplantation therapy
05/19/1998US5753480 Cysteinyl tRNA synthetase polynucleotides of streptococcus
05/19/1998US5753479 Genetic enginnering
05/19/1998US5753476 Identification of a human cytomegalovirus gene region involved in down regulation of MHC class I heavy chain expression
05/19/1998US5753432 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
05/19/1998US5753428 Synthetic composition for storage of platelets comprising glycerol
05/19/1998US5753270 Preparation comprising mixture of antiseptic and/or anesthetic terpene, phenolic compound or alcohol, quaternary ammonium antiseptic compound, iodine-containing antiseptic compound, dissolved in acetone
05/19/1998US5753269 Containing silver sulfadiazine
05/19/1998US5753265 Multiple unit pharmaceutical preparation
05/19/1998US5753263 Method to deliver compositions conferring resistance to alopecia to hair follicles
05/19/1998US5753260 Vaccines against sterols
05/19/1998US5753256 Plaster for the treatment of nail mycoses
05/19/1998US5753254 Includes disintegrating agent, flavoring agent, and lubricating agent
05/19/1998US5753247 Method of treating fungal infections
05/19/1998US5753242 Erythritol, hydrogenated lecithin, and polyoxyethylene added cholesterol derivative
05/19/1998US5753239 Bi-aromatic compounds and pharmaceutical and cosmetic compositions
05/19/1998US5753238 Target antigens of transmission blocking antibodies for malaria parasites
05/19/1998US5753237 Method for augmenting immunological responses
05/19/1998US5753235 Recombinant canine herpesviruses
05/19/1998US5753221 Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions
05/19/1998US5753218 Administering interleukin-10 and steroid
05/19/1998US5753213 Pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts for reducing seborrhea
05/19/1998US5753210 Sunscreen protective colloid comprising a ph indicator become discoloring when contact with the skin; cosmetics
05/19/1998US5752974 Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
05/19/1998CA2096611C 4-benzylpiperidine derivatives and process for their production
05/19/1998CA2093666C Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
05/19/1998CA2007507C Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
05/18/1998WO2006085895A2 Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies
05/15/1998CA2221090A1 Method of treating atherosclerosis
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020161A1 Methods for identifying genes essential to the growth of an organism
05/14/1998WO1998020146A2 Stabilized transient gene expression
05/14/1998WO1998020137A1 Human squalene epoxidase
05/14/1998WO1998020131A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
05/14/1998WO1998020126A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
05/14/1998WO1998020124A2 Diabetes-mediating proteins and therapeutic uses thereof
05/14/1998WO1998020119A1 Fatty-acid amide hydrolase
05/14/1998WO1998020109A1 Pressure-mediated intracellular delivery of molecules or microparticles
05/14/1998WO1998020095A2 Washing disinfectant for hygienic and surgical hand disinfection
05/14/1998WO1998020027A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
05/14/1998WO1998020023A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
05/14/1998WO1998020017A1 Modified nucleoside-5'-triphosphates
05/14/1998WO1998020013A1 New knoevenagel condensation products, method for their production and their use
05/14/1998WO1998020011A1 3-CARBOXAMIDE DERIVATIVES OF 5H-PYRROLO[2,1-c][1,4]-BENZODIAZEPINES
05/14/1998WO1998020010A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998WO1998020009A1 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor
05/14/1998WO1998020008A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998020005A1 Aryloxypropanolamine derivatives, method of preparation and applications thereof
05/14/1998WO1998020002A1 Dipyrido[2,3-b:3',2'-f]azepines and their use in the prevention or treatment of hiv infection
05/14/1998WO1998020000A2 Substituted 3-benzylpyrazoles
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019998A2 N-substituted 2-cyanopyrrolidines
05/14/1998WO1998019997A2 Dihydropyrones with improved antiviral activity
05/14/1998WO1998019996A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998WO1998019699A1 Use of growth hormone or a growth hormone secretagogue for promoting bone formation
05/14/1998WO1998019690A1 Method for treating alzheimer's disease
05/14/1998WO1998019685A1 Method of treating bronchitis with uridine triphosphates and related compounds
05/14/1998WO1998019683A1 Synergistic gold-containing compositions
05/14/1998WO1998019682A1 Certain aminosterol compounds and uses therefor
05/14/1998WO1998019681A1 Progesterone for treating or reducing ischemia
05/14/1998WO1998019680A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
05/14/1998WO1998019679A1 Cyclopentylxanthine derivatives for use in the treatment of cystic fibrosis
05/14/1998WO1998019678A1 Improved intraocular irrigating solution containing a polyamine antagonist
05/14/1998WO1998019677A1 Treatment of autoimmune diseases by photochemotherapy
05/14/1998WO1998019676A1 Method for treatment of glutamate related disorders
05/14/1998WO1998019675A1 Use of conjugated linoleic acid to enhance natural killer lymphocyte function
05/14/1998WO1998019674A2 A method for treating tension-type headache
05/14/1998WO1998019673A2 Anti-viral agents and methods relating to the use thereof
05/14/1998WO1998019672A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/14/1998WO1998019671A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
05/14/1998WO1998019669A1 Chewing gum containing colloidal bismuth subcitrate
05/14/1998WO1998019668A1 Delayed delivery system for acid-sensitive drugs
05/14/1998WO1998019667A1 Sustained release formulation containing dfmo
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998019648A2 N-oxy-naphthalimides as antibacterial agents
05/14/1998WO1998019545A1 Composition and method for the treatment of vaginal yeast infections
05/14/1998WO1998019513A2 Method for the preparation of citalopram
05/14/1998WO1998019512A2 Method for the preparation of citalopram
05/14/1998WO1998019511A2 Method for the preparation of citalopram
05/14/1998WO1998013009A3 Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis
05/14/1998WO1998010757A3 The use of functional N-methyl-D-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
1 ... 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 6669 6670 6671 6672 6673 6674 ... 7860